TotipotentRX

TotipotentRX is a leading regenerative medicine development company having eight autologous cell therapies in various stages of clinical development. We are the first commercial organization to embrace the U.S. FDA's Guidance that cellular therapies are combination products where both the therapeutic cells and the devices and methods to produce the... m must be tested and ultimately marketed as an integrated co-labeled therapeutic. We are also the world's only provider of cellular therapeutic development services being positioned at the intersection of personalized therapeutics and healthcare regenerative medicine services. We use the breadth and depth of our service offerings, our unmatched Indian footprint and our therapeutic, scientific and analytics expertise to help our regenerative medicine customers navigate the complex and challenging cellular therapy regulatory environment to improve efficiency and to deliver better clinical trial outcomes. Our partnerships with Fortis Healthcare, U.S. based core radiology laboratories, and global electronic data/database management teams enables us to add sophisticated statistical, independent data readers and advanced technology applications into our clinical development services to reach appropriate endpoints, drug therapy analysis, outcome and real-world research and evidence-based medicine. Additionally, our lower cost business solutions and experience in cell therapy enable our customers' objectives to be delivered on plan and within an affordable budget.Read More